PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

NIH spent $950M for basic or applied research leading to patents providing market exclusivity for drugs approved 2010-19

This represents

2023-07-26
(Press-News.org) BENTLEY UNIVERSITY

A new study from Bentley University’s Center for Integration of Science and Industry demonstrates that the National Institutes of Health (NIH) spent $950 million on basic or applied research associated with patents that provided manufacturers with market exclusivity. This amount represents <1% (0.59%) of the $164 billion in total NIH funding for research contributing to the approval of these products.  

The article in PLOS ONE titled “NIH funding for patents that contribute to market exclusivity of drugs approved 2010–2019 and the public interest protections of Bayh-Dole” is the first to look broadly at the NIH funding for the basic and applied research related to new drug approvals and the proportion of this research that leads to patents that give manufacturers market exclusivity. These patents are particularly important in that they provide manufacturers with monopoly production and pricing authority and are also subject to the public interest provisions of the Bayh-Dole Act intended to promote practical application of this research, availability at “reasonable terms,” a return on public sector investments, and broader economic growth.

This study focused on 313 drugs approved by the FDA from 2010-2019 with an entry in the DrugPatentWatch database that tracks patents cited as barriers to generic competition as well as those cited in litigation. The study shows that the NIH provided $164 billion in project (grant) funding for basic or applied research related to these drugs prior to first approval. Of this amount, only 0.59% ($0.95/$164 billion) of the NIH funding identified, including 0.38% ($0.52/$135) of NIH funding for basic research on the drug target and 1.5% ($0.44/$28.6) of NIH funding for applied research on the drugs themselves, was associated with patents in DrugPatentWatch. Significantly, while the study identified NIH-funded research related to each of the 313 drugs or their targets, only 34 (10.9%) had patents associated with NIH funding and only 29 (9.3%) had patents arising from research related to the drug or its target.

“We know that NIH funding supports approximately half of the cost of research and development leading to new drugs,” said Fred Ledley, Director of the Center for Integration of Science and Industry, and the senior author of this study. “This new research shows that very little of the taxpayer contribution to new drug approvals is subject to laws designed to protect the public interest and ensure an equitable balance between the interests of the public and those of commercial manufacturers.”

This work is one of a series of studies from the Center for Integration of Science and Industry characterizing the NIH’s contribution to new drug approvals and the role of government as a lead investor in pharmaceutical innovation. These studies demonstrate that the scale of NIH investment in new drug approvals is comparable to investment by industry, with >80% of NIH funding involving basic science and <5% involving phased clinical development. This pattern contributes to the limited number of patents associated with NIH-funded research, since patents require evidence of utility and the ability to achieve practical applications. 

Dr. Ledley was the lead author of this study with Dr. Ekaterina Galkina-Cleary.

DrugPatentWatch is a registered trademark of thinkBiotech LLC. The DrugPatentWatch database was obtained from DrugPatentWatch.com.

This work was supported by grants from the Institute for New Economic Thinking and the National Biomedical Research Foundation.

THE CENTER FOR INTEGRATION OF SCIENCE AND INDUSTRY at Bentley University focuses on advancing the translation of scientific discoveries to create public value. The Center is an environment for interdisciplinary scholarship spanning basic science, data analytics, business, and public policy. For more information, visit www.bentley.edu/sciindustry and follow us on Twitter @sciindustry and LinkedIn.

BENTLEY UNIVERSITY is one of the nation's top business schools and a lifelong-learning community that creates successful leaders who make business a force for positive change. With a combination of business and the arts and sciences and a flexible, personalized approach to education, Bentley provides students with critical thinking and practical skills that prepare them to lead successful, rewarding careers. Founded in 1917, the university enrolls >4,000 undergraduate, graduate, or PhD students and is set on 163 acres in Waltham, Massachusetts, 10 miles west of Boston. For more information, visit bentley.edu. Follow us on Twitter @BentleyU #BentleyUResearch.

END


ELSE PRESS RELEASES FROM THIS DATE:

People with heart failure can step their way to better health

2023-07-26
People with heart failure who increase their daily step count also saw improvements in their health status over a 12-week period, according to a study published today in JACC: Heart Failure. The study suggests that physical data from wearable devices, such as step count, can be clinically significant and has the potential to inform future clinical trials and clinical care. Consumer wearable devices to track health status and progress are commonly used and part of a growing trend of mobile health technology. However, how to interpret data from wearable devices, including step count, is at times ...

Ancient DNA reveals diverse community in “Lost City of the Incas”

2023-07-26
Who lived at Machu Picchu at its height? A new study, published today in Science Advances, used ancient DNA to find out for the first time where workers buried more than 500 years ago came from within the lost Inca Empire. Researchers, including Jason Nesbitt, associate professor of archaeology at Tulane University School of Liberal Arts, performed genetic testing on individuals buried at Machu Picchu in order to learn more about the people who lived and worked there. Machu Picchu is a UNESCO World Heritage Site located in the Cusco ...

Essential cell death-regulating mechanisms important for recovery from SARS-CoV infection and skin injury discovered

2023-07-26
Programmed cell death, a fundamental biological process that facilitates the elimination of old, damaged, infected, and non-functional cells, plays a crucial role in maintaining the balance between health and disease in the human body. Research by the team of Dr Alessandro Annibaldi from the Center for Molecular Medicine Cologne (CMMC) at the University of Cologne has uncovered a novel mechanism of cell death regulation, shedding light on its significance during conditions such as SARS-CoV infection and skin injury. The study ‘Cleavage ...

DNA analysis offers new insights into diverse community at Machu Picchu

2023-07-26
New Haven, Conn. — A genetic analysis suggests that the servants and retainers who lived, worked, and died at Machu Picchu, the renowned 15th century Inca palace in southern Peru, were a diverse community representing many different ethnic groups from across the Inca empire. The genomic data, described in a new study in Science Advances, is the first investigation of the genomic diversity of individuals buried at Machu Picchu and adjacent places around Cusco, the Inca capital. It builds upon previous archeological and bio-archaeological research, including a 2021 Yale-led study which found that Machu Picchu (AD 1420-1530) is older than was previously believed. “The ...

Lost metabolic fitness of CAR NK cells is key mechanism of tumor resistance

2023-07-26
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered loss of metabolic fitness in chimeric antigen receptor (CAR) natural killer (NK) cells is a critical mechanism of resistance, with infused cells gradually losing the ability to compete with tumor cells for nutrients, leading to tumor relapse. The study, published today in Science Advances, demonstrates that engineering CAR NK cells to express interleukin-15 (IL-15) enhances the cells’ metabolic fitness and provides a longer-lasting ...

Researchers develop machine learning models that could improve suicide-risk prediction among children

2023-07-26
A new study from UCLA Health researchers finds that the typical ways health systems store and track data on children receiving emergency care miss a sizable portion of those who are having self-injurious thoughts or behaviors. The researchers also found that several machine learning models they designed were significantly better at identifying those children at risk of self-harm.  Amid a nationwide youth mental health crisis, mental health providers are trying to improve their understanding of which children are at-risk of suicide or self-harm so providers can intervene earlier. However, health systems often ...

DOE announces $33 million to advance energy research across America

2023-07-26
WASHINGTON, D.C. — The U.S. Department of Energy (DOE) today announced $33 million to support 14 clean-energy research projects as part of a program to ensure the Department’s research funding is reaching pockets of the country that traditionally have received disproportionally low amounts of Federal scientific funding. The projects will cover a range of topics—including grid integration, renewable solar and wind energy, and advanced manufacturing. Today’s funding will help ensure all regions of the country share in the ownership of priority research that advances science and addresses energy ...

Predicting lifespan-extending chemical compounds for C. elegans with machine learning

Predicting lifespan-extending chemical compounds for C. elegans with machine learning
2023-07-26
“We created datasets for predicting whether or not a compound extends the lifespan of C. elegans [...]” BUFFALO, NY- July 26, 2023 – A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 13, entitled, “Predicting lifespan-extending chemical compounds for C. elegans with machine learning and biologically interpretable features.” Recently, there has been a growing interest in the development of pharmacological interventions targeting ...

KIAA0930: A cachexic phenotype inducer in cancer cells

KIAA0930: A cachexic phenotype inducer in cancer cells
2023-07-26
“We believe that KIAA0930 would be a novel cachexia therapeutic target.” BUFFALO, NY- July 26, 2023 – A new research paper was published in Oncotarget's Volume 14 on July 20, 2023, entitled, “The uncharacterized transcript KIAA0930 confers a cachexic phenotype on cancer cells.” Patients with cancer cachexia have a poor prognosis and impaired quality of life. Numerous studies using preclinical models have shown that inflammatory cytokines play an important role in the development of cancer cachexia; however, no clinical trial targeting cytokines has been successful. Therefore, ...

Lifespan of ageing science’s model organism driven by reproductive self-destruction

2023-07-26
The lifespan of a small roundworm that has been used as a key model organism in ageing research is limited by how it self-sacrifices to feed its young, finds a new study led by UCL researchers. The authors of the new Nature Communications paper say their findings raise questions about how well insights from the Caenorhabditis elegans (C. elegans) worm can be translated to human ageing advances. C. elegans is widely used as a laboratory animal, and has been central to ageing research for 40 years thanks to discoveries of genes that can be supressed to produce up to a tenfold increase in ...

LAST 30 PRESS RELEASES:

Youngest in class at higher risk of mental health problems

American Heart Association announces new volunteer leaders for 2025-26

Gut microbiota analysis can help catch gestational diabetes

FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship

Champions for change – Paid time off initiative just made clinical trials participation easier

Fentanyl detection through packaging

Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics

New 3D glacier visualizations provide insights into a hotter Earth

Creativity across disciplines

Consequences of low Antarctic sea ice

Hear here: How loudness and acoustic cues help us judge where a speaker is facing

A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America

Epilepsy self-management program shows promise to control seizures, improve mood and quality of life

Fat may play an important role in brain metabolism

New study finds no lasting impact of pandemic pet ownership on human well-being

New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects

Gut microbes could protect us from toxic ‘forever chemicals’

Novel modelling links sea ice loss to Antarctic ice shelf calving events

Scientists can tell how fast you're aging from a single brain scan

U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050

Public take the lead in discovery of new exploding star

What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids

ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000

Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work

Turning social fragmentation into action through discovering relatedness

Cheese may really be giving you nightmares, scientists find

Study reveals most common medical emergencies in schools

Breathable yet protective: Next-gen medical textiles with micro/nano networks

Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems

Developed an AI-based classification system for facial pigmented lesions

[Press-News.org] NIH spent $950M for basic or applied research leading to patents providing market exclusivity for drugs approved 2010-19
This represents